YZi Labs (CZ's family office) challenges CEA Industries' poison pill and treasury strategy. Learn about the fight for the $464M BNB treasury.

The BNB Treasury War: YZi Labs, CEA Industries, and the Fight for Governance

A High-Stakes Governance Crisis

The start of January 2026 has been marked by a significant escalation in the proxy battle for CEA Industries Inc. (Nasdaq: BNC). YZILabs Management Ltd. (YZi Labs), a primary stakeholder backed by Changpeng Zhao (CZ), has officially challenged the company’s newly adopted "Stockholder Rights Plan" and defensive bylaw amendments.

The "Poison Pill" Mechanism

On December 28, 2025, the BNC board implemented a 15% poison pill. Under this plan, if any shareholder or group acquires more than 15% of the common stock without board approval, other shareholders are granted the right to purchase additional shares at a 50% discount, effectively diluting the "hostile" party.

YZi Labs, which already beneficially owns a significant portion of the company through warrants (potentially up to 34.2% on a diluted basis), views this as a direct attempt to "entrench" a board that has lost shareholder confidence.

The BNB vs. Solana Treasury Strategy

The heart of the conflict lies in the Digital Asset Treasury (DAT) strategy.

• The Mandate: In July 2025, BNC received a $500M PIPE investment specifically to become the world’s largest corporate holder of BNB.

• The Allegation: YZi Labs claims that CEO David Namdar and board member Hans Thomas have been promoting alternative "competitive" DAT ventures and considering a pivot to Solana ($SOL$).

• The Defense: BNC management has denied these claims, reaffirming their commitment to BNB and highlighting their current holdings of 515,554 BNB (valued at ~$464.6M).

The Consent Solicitation Process

YZi Labs has now moved to bypass the traditional annual meeting—which BNC has delayed—by filing a preliminary consent statement with the SEC. This process allows YZi to collect written "votes" from shareholders to expand the board of directors and elect its own nominees. YZi’s slate includes industry veterans such as Max Baucus and Matthew Roszak.

Conclusion

The outcome of this fight will define the future of corporate cryptocurrency treasuries in the United States. If YZi Labs succeeds, BNC will likely double down on its BNB-centric mission. If the board's "poison pill" holds, it could signal a broader shift in how public companies manage digital asset mandates.